Implicity’s alert-based Cardiac Remote Monitoring platform provides a comprehensive solution for health professionals seeking accurate and efficient cardiovascular monitoring. Our AI-driven technology transforms and aggregates data from all cardiac electronic implantable devices, regardless of vendor, to meet your specific needs.
Designed by an Electrophysiologist, our platform addresses the exact pain points experienced in daily practice. With Implicity, you can easily manage your remote monitored CIED patients.
One comprehensive remote monitoring solution to manage all CIEDs
Effortlessly enhance patient care and optimise device clinic efficiency
No software to install and no update needed. You will always have the latest version
Implicity was created by an electrophysiologist for physicians. Our intuitive platform meets the operational needs of healthcare professionals
Available in less than 24 hours
See the data of your patients within 24 hours and start enjoying our smart-monitoring platform
Follow the status of your patients anywhere and anytime. EU data privacy compliant, all our solutions guarantee secure access and data encryption
Discover Implicity’s unique features
Patient Connectivity Management
Reduce the number of non-transmitting patients by 60%1 using automated text message reminders.
AF Alert Management2
Detect clinically relevant events proven to lead to an 85% decrease in unnecessary AF alerts compared to alerts transmitted by a CIED.
Dynamic Revenue Automation
Achieve 90%+ billing compliance3 with optimized scheduling and auto-generated reports.
Implicity Remote Monitoring: Associated with Reduced Mortality, Hospitalisation Rates
During this year’s Heart Rhythm Society, Professor Niraj Varma presented a Late Breaking Abstract titled “Clinical impact of a universal remote monitoring platform for ICD and CRT-D follow-up from a large real-world registry.” The abstract highlighted that the Implicity remote cardiac monitoring platform is associated with reduced mortality by 22% and reduced hospitalisation by 4% vs. conventional remote monitoring.
These impressive results support the recent expert consensus statement released by HRS/EHRA/APHRS/LAHRS during this year’s annual Heart Rhythm Scientific Program in New Orleans on the “Practical Management of the Remote Device Clinic” which highlights in detail the importance of third-party resources for remote monitoring efficiency.
1. Number of patients connected within 2 weeks compared to no action. Based on Implicity data covering over 17,680 patients. 2. IM009: 2021. Manufacturer: Implicity. IM009 is a software as a medical device (SaMD) intended to be used as an adjunct of a remote monitoring platform to follow-up target population patients. Im009 IS NOT APPROVED IN AUSTRALIA 3. Jay Ganji, MD, FACC, Cardiologist, Piedmont Cardiovascular, November 2022.